Prospective study to evaluate radioactive iodine of 20 mCi vs 10-15 mCi in Graves' disease.

Objectives: To assess whether increasing radioactive iodine dose can increase treatment efficacy in Graves' disease.

Methods: A prospective study was conducted, including 106 patients receiving 20 mCi (740 MBq) radioactive iodine (RAI), compared with a retrospective data, including 113 patients receiving 10-15 mCi (370-555 MBq) RAI. Remission and failure rates were evaluated at 6 months post-RAI.

Incidence and treatment outcomes of Graves' disease in Thailand: a single-center retrospective observational study.

Background: Treatment patterns and outcomes of Graves' disease (GD) are variable around the world. However, studies on treatment outcomes of GD from the Asian populations are limited. We aimed to evaluate treatment outcomes of GD in Thailand.

Risk-stratified papillary thyroid microcarcinoma: post-operative management and treatment outcome in a single center.

Purpose: This article aims to review and assess the post-operative management and treatment outcomes of papillary thyroid microcarcinoma (PTMC) in risk-stratified patients.

Methods: We retrospectively analyzed the data of PTMC patients who underwent thyroid surgery with or without radioactive iodine treatment (RAI) in a single center between January 2011 and December 2017. Demographic and clinicopathologic data were collected.